MRNA

Moderna
D

MRNA

26.680
USD
-0.67
(-2.45%)
مغلق
حجم التداول
434,122
الربح لكل سهم
-11
العائد الربحي
-
P/E
-3
حجم السوق
10,318,271,758
التوصيات
Abdilatif
Abdilatif
منذ شهرين
buy
MRNA
MRNA@26.15
2025-04-14 06:32
MRNA@26.15 Chart
الربح
164.25
Abdilatif
Abdilatif
منذ سنة
sell
MRNA
MRNA@101.02
2024-02-01 03:45
MRNA@101.02 Chart
الربح
357.00
Abdilatif
Abdilatif
منذ سنة
sell
MRNA
MRNA@101.83
2024-01-29 04:09
MRNA@101.83 Chart
الربح
-175.00
المزيد
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 8 أشهر
neutral
2024-10-01 04:30
MRNA Chart
المزيد
أصول ذات صلة
AZN
AZN
-0.575
(-0.77%)
74.425 USD
BNTX
BNTX
1.870
(1.78%)
106.710 USD
GSK
GSK
-1.630
(-3.84%)
40.840 USD
I
INO
-0.07000
(-3.38%)
2.00000 USD
JNJ
JNJ
0.425
(0.27%)
157.090 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
N
NVAX
-0.22000
(-3.08%)
6.93000 USD
PFE
PFE
-0.315
(-1.27%)
24.535 USD
T
TDOC
-0.32000
(-4.46%)
6.85500 USD
المزيد
الأخبار المقالات

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.